Ilson DH - Search Results

1

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.

Cytryn SL, Moy RH, Cowzer D, Shah RH, Chou JF, Joshi SS, Ku GY, Maron SB, Desai A, Yang J, Sugarman R, Rao D, Goldberg Z, Charalambous C, Lapshina M, Antoine A, Socolow F, Trivedi N, Capanu M, Gerdes H, Schattner MA, Simmons M, Lacouture ME, Paroder V, Tang LH, Shia J, Ilson DH, Solit DB, Berger MF, Janjigian YY. Cytryn SL, et al. Among authors: ilson dh. Lancet Oncol. 2023 Oct;24(10):1073-1082. doi: 10.1016/S1470-2045(23)00358-3. Epub 2023 Sep 1. Lancet Oncol. 2023. PMID: 37666264 Free PMC article. Clinical Trial.

2

A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary report.

Kelsen D, Ajani J, Ilson D, Daugherty K, Pazdur R. Kelsen D, et al. Semin Oncol. 1994 Oct;21(5 Suppl 8):44-8. Semin Oncol. 1994. PMID: 7524158 Clinical Trial.

3

A phase II study of topotecan administered five times daily in patients with advanced gastric cancer.

Saltz LB, Schwartz GK, Ilson DH, Quan V, Kelsen DP. Saltz LB, et al. Among authors: ilson dh. Am J Clin Oncol. 1997 Dec;20(6):621-5. doi: 10.1097/00000421-199712000-00018. Am J Clin Oncol. 1997. PMID: 9391553 Clinical Trial.

4

A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.

Kelsen D, Ginsberg R, Bains M, Cooper J, Arquette M, Forastiere AA, Ilson D. Kelsen D, et al. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-77-S19-81. Semin Oncol. 1997. PMID: 9427272 Clinical Trial.

5

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP. Ilson DH, et al. J Clin Oncol. 1998 May;16(5):1826-34. doi: 10.1200/JCO.1998.16.5.1826. J Clin Oncol. 1998. PMID: 9586897 Clinical Trial.

6

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.

Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP. Ilson DH, et al. J Clin Oncol. 1999 Oct;17(10):3270-5. doi: 10.1200/JCO.1999.17.10.3270. J Clin Oncol. 1999. PMID: 10506629 Clinical Trial.

7

Chemotherapy in esophageal cancer.

Enzinger PC, Ilson DH, Kelsen DP. Enzinger PC, et al. Among authors: ilson dh. Semin Oncol. 1999 Oct;26(5 Suppl 15):12-20. Semin Oncol. 1999. PMID: 10566606 Review.

8

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.

Ilson DH, Bains M, Kelsen DP, O'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD. Ilson DH, et al. J Clin Oncol. 2003 Aug 1;21(15):2926-32. doi: 10.1200/JCO.2003.02.147. J Clin Oncol. 2003. PMID: 12885811 Clinical Trial.

9

Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.

Ilson DH. Ilson DH. Oncology (Williston Park). 2004 Dec;18(14 Suppl 14):22-5. Oncology (Williston Park). 2004. PMID: 15685830 Free article. Clinical Trial.

10

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

Shah MA, Ramanathan RK, Ilson DH, Levnor A, D'Adamo D, O'Reilly E, Tse A, Trocola R, Schwartz L, Capanu M, Schwartz GK, Kelsen DP. Shah MA, et al. Among authors: ilson dh. J Clin Oncol. 2006 Nov 20;24(33):5201-6. doi: 10.1200/JCO.2006.08.0887. J Clin Oncol. 2006. PMID: 17114652 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters